Medical devices, healthcare technology and the business of care
510(k) clearance · K254181

Aristotle 65 Macrowire

Scientia Vascular · Decision date Sep 16, 2026

MEDTECHLEDGER EXPLANATIONK254181

What did the FDA decide?

The FDA recorded a substantial equivalence decision, dated 2026-09-16, for Scientia Vascular's Aristotle 65 Macrowire under premarket notification K254181, in the Cardiovascular specialty with product code MOF. The letter describes the device as intended for general vascular use within the neuro and peripheral vasculatures to introduce and position catheters. Substantial equivalence is a clearance, not approval of a premarket approval application.

The excerpts indicate the submission included risk assessments conducted in accordance with ISO 14971:2019 and performance testing on the subject devices, and that the letter restates Quality Management System Regulation obligations, including ISO 13485 design-control and corrective-action clauses. The excerpts do not identify a predicate device, the specific tests or results, or any cleared labeling beyond the stated intended use, so those details remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254181
Regulatory pathway
510(k) premarket notification
Product code
MOF
Decision code
SESE
Decision date
Sep 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Guide, Wire, Catheter, Neurovasculature.

Product code
MOF
FDA device class
2

FDA decision timeline

  1. K254181 received

    Application receipt date recorded by FDA.

  2. K254181 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MOF

Product / regulatory recordCompanyPathwayDecision dateSource
Piraeus Medical, Inc.510(k) clearanceAug 27, 2026FDA
Arbor Endovascular, LLC510(k) clearanceAug 14, 2026FDA
Scientia Vascular, Inc.510(k) clearanceAug 6, 2026FDA
Rapid-Medical , Ltd.510(k) clearanceJul 17, 2026FDA
Scientia Vascular, Inc.510(k) clearanceApr 29, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Scientia Vascular

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
West Valley City, UT

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records